1. Home
  2. BIAF vs ABTS Comparison

BIAF vs ABTS Comparison

Compare BIAF & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • ABTS
  • Stock Information
  • Founded
  • BIAF 2014
  • ABTS 2010
  • Country
  • BIAF United States
  • ABTS Hong Kong
  • Employees
  • BIAF N/A
  • ABTS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • BIAF Health Care
  • ABTS Technology
  • Exchange
  • BIAF Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • BIAF 14.5M
  • ABTS 16.0M
  • IPO Year
  • BIAF 2022
  • ABTS N/A
  • Fundamental
  • Price
  • BIAF $0.99
  • ABTS $0.46
  • Analyst Decision
  • BIAF Strong Buy
  • ABTS
  • Analyst Count
  • BIAF 1
  • ABTS 0
  • Target Price
  • BIAF $6.00
  • ABTS N/A
  • AVG Volume (30 Days)
  • BIAF 148.8K
  • ABTS 89.5K
  • Earning Date
  • BIAF 11-14-2024
  • ABTS 12-31-2024
  • Dividend Yield
  • BIAF N/A
  • ABTS N/A
  • EPS Growth
  • BIAF N/A
  • ABTS N/A
  • EPS
  • BIAF N/A
  • ABTS N/A
  • Revenue
  • BIAF $9,367,785.00
  • ABTS $5,343,888.00
  • Revenue This Year
  • BIAF $285.51
  • ABTS N/A
  • Revenue Next Year
  • BIAF $20.05
  • ABTS N/A
  • P/E Ratio
  • BIAF N/A
  • ABTS N/A
  • Revenue Growth
  • BIAF 2813.87
  • ABTS 3970.67
  • 52 Week Low
  • BIAF $0.83
  • ABTS $0.38
  • 52 Week High
  • BIAF $3.62
  • ABTS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 41.69
  • ABTS 40.47
  • Support Level
  • BIAF $0.83
  • ABTS $0.41
  • Resistance Level
  • BIAF $1.04
  • ABTS $0.58
  • Average True Range (ATR)
  • BIAF 0.13
  • ABTS 0.07
  • MACD
  • BIAF 0.02
  • ABTS -0.02
  • Stochastic Oscillator
  • BIAF 35.25
  • ABTS 14.52

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

Share on Social Networks: